B

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Associate Scientist Quality Control in vivo

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timePlanegg, GermanyNo salary listedIn-person

About the Job

Requirements

  • Postgraduate academic education in biosciences or life sciences, such as a PhD, Dr. rer. nat., or Dr. med. vet. in a relevant field.
  • Hands-on experience coordinating, supervising, and documenting in vivo studies in mice or rodents.
  • Knowledge of German animal welfare legislation.
  • Experience with GMP quality standards.
  • Excellent written and spoken English.
  • German language skills are an advantage.

Responsibilities

  • Plan, supervise, and execute in vivo quality-control experiments in mice under GMP for release of vaccine products in a BSL3 animal facility.
  • Work as part of the scientific leads team for QC in vivo and coordinate scientifically and organizationally within the QC department.
  • Ensure testing readiness, including qualification and validation of equipment and laboratories, and oversee sample flow, reagent logistics, and material logistics.
  • Maintain GMP quality standards, including authoring and reviewing GMP documents and working within the Quality Management System.
  • Support planning and alignment with stakeholders across departments.
  • Support inspections and audits and communicate with animal welfare and GMP authorities.

Desired Qualifications

  • Two to three years of work experience in the pharmaceutical or biotech industry.
  • Experience with equipment qualification and laboratory coordination.

About the Company

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Bavarian Nordic develops, manufactures, and sells vaccines and cancer immunotherapies. Its vaccines and immunotherapies aim to train the body's immune system to recognize and attack cancer cells or infectious agents. The company operates as a fully integrated biotechnology business, handling development, production, and commercialization, and it collaborates with partners and licensing agreements to bring its products to market. A key differentiator is its track record, including European marketing authorization for an Ebola vaccine and a licensing deal for a COVID-19 vaccine, plus ongoing partnerships. The company's goal is to improve global health by reducing the risk of infectious diseases and by improving cancer treatment outcomes.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
1994

Recently Posted Jobs

Explore more opportunities at Bavarian Nordic

See more jobs